- within Finance and Banking topic(s)
- in United States
- with readers working within the Pharmaceuticals & BioTech industries
- within Immigration, Consumer Protection and Transport topic(s)
South Africa is moving closer to one of the most significant changes to its over-the-counter (“OTC”) derivatives market in more than a decade. While the proposals have largely stayed within specialist financial markets, recent confirmation from the South African Reserve Bank (“SARB”) that the final central clearing framework is expected to come into effect by 2028 shows that implementation is now firmly on the regulatory horizon.
The proposed reforms are part of South Africa’s ongoing effort to align its OTC derivatives framework with international standards developed after the 2008 global financial crisis. The goal is simple: reduce systemic risk, improve transparency and strengthen the financial system by requiring certain standardised OTC derivatives to be centrally cleared.
The proposals are not entirely new. South Africa adopted a phased roadmap for mandatory central clearing in 2022, and the Prudential Authority (“PA”) and Financial Sector Conduct Authority (“FSCA”) have since been working towards a framework that determines which products should be subject to mandatory clearing and under what circumstances. Industry consultation on the initial discussion document closed in June 2026, and regulators have now indicated that the final framework is expected to be operational by 2028, subject to the licensing and operational readiness of an appropriate central counterparty.
The announcement represents an important milestone for South Africa’s derivatives market, particularly given its size. According to the SARB, South African rand-linked OTC derivatives traded onshore and offshore exceed ZAR150 trillion in value. While these markets generally function efficiently, they remain exposed to counterparty credit risk where transactions are settled directly between market participants.
Central clearing addresses that risk by placing a licensed central counterparty between the contracting parties. Instead of each participant bearing the credit risk of its counterparty, the central counterparty becomes the buyer to every seller and the seller to every buyer. This greatly reduces the chance that the failure of a single market participant could cause wider disruption across the financial system.
The initial proposals suggest that rand-denominated interest rate swaps and forward rate agreements will be the first OTC products subject to mandatory clearing. Regulators have indicated that additional derivative classes will be introduced gradually through a phased approach based on industry engagement, market data and practical considerations. This step-by-step approach is consistent with international practice and recognises that mandatory clearing should be expanded only where markets have sufficient liquidity, standardisation and operational maturity.
Although much attention naturally focuses on banks and large financial institutions, the reforms are likely to have broader implications across the financial services industry. Asset managers, insurers, pension funds, corporates and other participants active in OTC derivatives markets will need to assess whether their existing trading arrangements, collateral management processes and operational systems remain appropriate under a mandatory clearing regime.
Implementation will also require careful coordination between regulatory authorities and market infrastructure providers. The SARB has acknowledged that mandatory clearing will only begin once an appropriate central counterparty is licensed and operational. At present, South Africa has a licensed central counterparty for listed derivatives through JSE Clear, but the proposed framework envisions a broader clearing ecosystem for qualifying OTC products.
From a policy perspective, the reforms also reflect South Africa’s continued alignment with G20 commitments aimed at improving the safety and transparency of global derivatives markets. Since the financial crisis, jurisdictions across Europe, the United States, the United Kingdom and Asia have progressively introduced mandatory clearing requirements for standardised OTC derivatives. South Africa’s framework therefore represents part of a broader international regulatory trend rather than an isolated domestic initiative.
For market participants, however, these developments matter beyond regulatory compliance. Mandatory central clearing may affect trading costs, collateral requirements, documentation, operational workflows and counterparty arrangements. Firms that currently transact bilaterally may need to reconsider their clearing models, onboarding processes and contractual documentation well before the rules take effect.
While the final standards have not yet been published, regulators have indicated that the PA and the FSCA intend to issue a joint standard for consultation between April 2027 and March 2028, together with a draft joint determination identifying the products that will become subject to mandatory clearing. These documents will also establish the eligibility criteria applicable to mandatory clearing and provide greater certainty regarding implementation.
The period before implementation is therefore an important opportunity for market participants to review their current derivatives activities, engage with the consultation process and identify any operational or legal changes that may be needed. Businesses that leave these assessments until the final rules are published may find themselves working within tight implementation timelines.
The gradual introduction of mandatory central clearing shows a careful regulatory approach. Rather than imposing immediate obligations across the entire market, regulators appear committed to balancing financial stability goals with practical implementation challenges. This approach should give participants greater certainty while allowing market infrastructure to develop alongside the evolving regulatory framework.
Although 2028 may seem some distance away, the direction is now clear. South Africa’s OTC derivatives market is moving towards a more transparent, standardised and resilient clearing framework that mirrors developments in major international financial markets. As further consultation documents emerge over the coming months, institutions in the derivatives market should keep monitoring these developments closely and start considering how the proposed reforms may affect their existing trading and risk management arrangements.
Our Banking and Finance team continues to monitor developments relating to South Africa’s OTC derivatives framework and assists clients in assessing the potential legal and operational implications of evolving market infrastructure and financial market regulation.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
[View Source]